Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Influenza Medications Market

Influenza Medications Market Trends

  • Report ID: GMI8695
  • Published Date: Mar 2024
  • Report Format: PDF

Influenza Medications Market Trends

With the rising number of influenza cases, there is a higher demand for drugs to treat and prevent the illness. Health professionals and the public are increasingly aware of the importance of early diagnosis and treatment of influenza. The availability of effective treatments, such as antibiotics has increased the acceptance of influenza vaccines by health care providers and patients. To that end, many individuals are seeking treatment for influenza symptoms, leading to increased market growth.

Pharmaceutical companies and research institutions are further actively involved in R&D activities aimed at discovering and developing new influenza drugs. These efforts are driven by the necessity to address challenges, such as antiviral resistance, limited treatment options, and the potential for future influenza pandemics.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Influenza medications market size was USD 942.6 million in 2023 and is expected to register 2.9% CAGR from 2024-2032 owing to the increasing prevalence of influenza worldwide.

Influenza medications industry from the antiviral drugs segment generated USD 520.3 million in 2023 and is expected to register 3.4% CAGR from 2024-2032 due to being considered as the primary treatment for influenza infections.

North America influenza medications industry size is expected to reach USD 548.7 million by 2032 due to a significant burden of influenza infections annually, along with population density, international travel, and seasonal variations.

AstraZeneca plc, BioCryst Pharmaceuticals, Inc., Daiichi Sankyo Company, F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Lupin, NATCO Pharma Limited, Novartis AG, Sanofi, and Teva Pharmaceutical Industries Ltd., are some of the major influenza medications companies worldwide.

Influenza Medications Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 454
  • Countries covered: 19
  • Pages: 267
 Download Free Sample